Skip to main content
. 2021 Nov 13;108(12):1448–1464. doi: 10.1093/bjs/znab336

Table 1.

Sociodemographic and operative differences between the prepandemic and pandemic cohorts

Before pandemic Pandemic
(n = 3031) (n = 4371)
Age (years)
  < 60 890 (29.4) 1391 (31.8)
  60–69 926 (30.6) 1287 (29.4)
  > 70 1215 (40.1) 1693 (38.7)
Sex
  F 1430 (47.2) 2214 (50.7)
  M 1601 (52.8) 2157 (49.3)
ASA grade
  I–II 1956 (68.9) 3005 (69.0)
  III–V 883 (31.1) 1347 (31.0)
Obese (BMI ≥ 30 kg/m2)
  No 1823 (68.3) 3167 (76.6)
  Yes 848 (31.7) 970 (23.4)
Smoker
  Not current 2699 (89.0) 3962 (90.6)
  Current 332 (11.0) 409 (9.4)
Chronic lung disease
  No 2541 (83.8) 3912 (89.5)
  Yes 490 (16.2) 459 (10.5)
Cardiovascular disease
  No 1804 (59.5) 2238 (51.2)
  Yes 1227 (40.5) 2133 (48.8)
Diabetes mellitus
  No 2586 (85.3) 3582 (81.9)
  Yes 445 (14.7) 789 (18.1)
Operative approach
  Minimally invasive 1709 (56.4) 2061 (47.2)
  Open 1321 (43.6) 2308 (52.8)
Operative site
  Lower abdominal 2457 (81.1) 3400 (77.8)
  Upper abdominal 451 (14.9) 856 (19.6)
  Thoracoabdominal 123 (4.1) 115 (2.6)
Operative complexity
  Intermediate/major 1970 (65.0) 3124 (71.5)
  Complex major 1061 (35.0) 1247 (28.5)
Surgical specialty
  Lower gastrointestinal 1180 (38.9) 2188 (50.1)
  Upper gastrointestinal 257 (8.5) 374 (8.6)
  Hepatopancreatobiliary 279 (9.2) 573 (13.1)
  Urology 719 (23.7) 357 (8.2)
  Gynaecology 596 (19.7) 879 (20.1)
Country World Bank classification
  Low and middle income 0 (0) 541 (12.4)
  High income 3031 (100) 3830 (87.6)
30-day pulmonary complication
  No 2821 (93.1) 4097 (93.7)
  Yes 216 (7.1) 274 (6.3)
30-day mortality
  No 3011 (99.3) 4284 (98.0)
  Yes 20 (0.7) 87 (2.0)
SARS-COV-2 diagnosis
  No 3031 (100) 4147 (94.9)
  Yes 0 (0) 187 (4.3)

Values in parentheses are percentages. SARS-COV-2, severe acute respiratory syndrome coronavirus 2.